Ezra M Friedberg, a director at $PTHS, sold 5,999 shares of the company on 11-25-2025 for an estimated $167,972. We received data on the trade from a recent SEC filing. This was a sale of approximately 15.0% of their shares of this class of stock. Following this trade, they now own 34,001 shares of this class of $PTHS stock.
$PTHS Insider Trading Activity
$PTHS insiders have traded $PTHS stock on the open market 4 times in the past 6 months. Of those trades, 0 have been purchases and 4 have been sales.
Here’s a breakdown of recent trading of $PTHS stock by insiders over the last 6 months:
- EZRA M FRIEDBERG has made 0 purchases and 4 sales selling 10,000 shares for an estimated $280,280.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$PTHS Hedge Fund Activity
We have seen 14 institutional investors add shares of $PTHS stock to their portfolio, and 0 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- MURCHINSON LTD. added 280,000 shares (+inf%) to their portfolio in Q3 2025, for an estimated $7,840,000
- VANGUARD GROUP INC added 66,836 shares (+inf%) to their portfolio in Q3 2025, for an estimated $1,871,408
- IKARIAN CAPITAL, LLC added 62,451 shares (+inf%) to their portfolio in Q3 2025, for an estimated $1,748,628
- BOOTHBAY FUND MANAGEMENT, LLC added 21,245 shares (+inf%) to their portfolio in Q3 2025, for an estimated $594,860
- DIADEMA PARTNERS LP added 10,498 shares (+inf%) to their portfolio in Q3 2025, for an estimated $293,944
- GEODE CAPITAL MANAGEMENT, LLC added 10,330 shares (+inf%) to their portfolio in Q3 2025, for an estimated $289,240
- KNOTT DAVID M JR added 6,112 shares (+inf%) to their portfolio in Q3 2025, for an estimated $171,136
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$PTHS Analyst Ratings
Wall Street analysts have issued reports on $PTHS in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Roth Capital issued a "Buy" rating on 11/25/2025
- Oppenheimer issued a "Outperform" rating on 11/14/2025
To track analyst ratings and price targets for $PTHS, check out Quiver Quantitative's $PTHS forecast page.
$PTHS Price Targets
Multiple analysts have issued price targets for $PTHS recently. We have seen 2 analysts offer price targets for $PTHS in the last 6 months, with a median target of $57.0.
Here are some recent targets:
- Jonathan Aschoff from Roth Capital set a target price of $57.0 on 11/25/2025
- Jeff Jones from Oppenheimer set a target price of $57.0 on 11/14/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
